Major Trial in Atrial Fibrillation Stopped Prematurely
Sensible Medicine
NOVEMBER 20, 2023
I received a text message from a colleague last night during dinner that a trial we were part of, called OCEANIC AF , was being terminated early by the data safety monitoring board. This morning, the makers of asundexian had a press release up on its site. This is huge news in cardiology. But it is also worthy of a column here because we at Sensible Medicine are interested in how new therapies are tested.
Let's personalize your content